Artwork for podcast The Dr. Geo Podcast
Urine Tests for Prostate Cancer with Dr. Jason Alter
Episode 4618th January 2023 • The Dr. Geo Podcast • Dr. Geo Espinosa
00:00:00 01:00:14

Share Episode


Dr. Jason M. Alter is the Head of Scientific Affairs for Exosome Diagnostics.

He has extensive experience in prognostic and predictive testing in Urologic Oncology. He has played key roles in the development of prostate cancer assays (biopsy and post-radical prostatectomy) at multiple companies.

Dr. Alter has published on genomic and non-genomic risk assessment methods for prostate cancer and is very familiar with available molecular and genomic testing for the disease.

Dr. Alter has a dual B.A. in Biology and History from Alfred University, an M.S. degree in Immuno-Parasitology from Texas A&M University, and a Ph.D. in Molecular Biology from Binghamton University.

He did a postdoctoral fellowship at Schering Plough Pharmaceuticals.

In this episode, Dr. Geo and Dr. Alter discuss the effectiveness of urine tests in identifying prostate cancer.


Thanks for listening to this week's episode.

Subscribe to The Dr. Geo Youtube Channel to get more content like this and learn how YOU can live better with age. 

Join below:

You can also listen to this episode and future episodes of the Dr. Geo Podcast by clicking the link below:

The Dr. Geo Podcast:


Follow Dr. Geo on Social Media



Become a member of Dr. Geo’s community and go to:

Improve your urological health with Dr. Geo’s formulated supplement lines

XY Wellness:

Mr. Happy:

You can also check out Dr. Geo’s other supplement recommendations for overall health and wellness


DISCLAIMER: This audio is educational and does not constitute medical advice. The content of this audio is my personal opinion and not that of my employer(s). 

Use of this information is at your own risk. Geovanni Espinosa, N.D., will not assume any liability for any direct or indirect losses or damages that may result from the use of the information contained in this video, including but not limited to economic loss, injury, illness, or death.